Last reviewed · How we verify
Human immunoglobulin — Competitive Intelligence Brief
marketed
Human Immunoglobulin G [EPC]
Small molecule
Live · refreshed every 30 min
Target snapshot
Human immunoglobulin (Human immunoglobulin) — Centre Hospitalier St Anne.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Human immunoglobulin TARGET | Human immunoglobulin | Centre Hospitalier St Anne | marketed | Human Immunoglobulin G [EPC] | ||
| HUMAN IMMUNOGLOBULIN G | HUMAN IMMUNOGLOBULIN G | marketed | Human Immunoglobulin G [EPC] | 2006-01-01 | ||
| Botulinum neurotoxin | Botulinum neurotoxin | University of Miami | marketed | Human Immunoglobulin G [EPC] |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Human Immunoglobulin G [EPC] class)
- · 1 drug in this class
- Centre Hospitalier St Anne · 1 drug in this class
- University of Miami · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Human immunoglobulin CI watch — RSS
- Human immunoglobulin CI watch — Atom
- Human immunoglobulin CI watch — JSON
- Human immunoglobulin alone — RSS
- Whole Human Immunoglobulin G [EPC] class — RSS
Cite this brief
Drug Landscape (2026). Human immunoglobulin — Competitive Intelligence Brief. https://druglandscape.com/ci/human-immunoglobulin. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab